loader
Please Wait
Applying Filters...

Bora CDMO Bora CDMO

X

Product List of all Active Pharmaceutical Ingredients (APIs) supplied/manufactured by Suzhou Tianma Pharma Group Co Ltd

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 Eribulin (1)

02 Rebamipide (2)

03 Semaglutide (1)

filter

01 Active (2)

02 Blank (2)

filter

01 Blank (4)

filter

01 223MF10143 (1)

02 305MF10002 (1)

03 Blank (2)

filter

01 Blank (4)

URL Supplier Web Content
See all info for this product

See Less

USDMF

Found USDMF

34819
Active
ERIBULIN FRAGMENT A
2020-08-06
CEP/COS

Close CEP/COS

Japanese DMF

Close JDMF

Written Confirmation

Close WC

Application Number
34819
Status
Active
Fees Unpaid
N/A
 
Filing Details
ERIBULIN FRAGMENT A
Issue/Submission Date
2020-08-06
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
See all info for this product

See Less

USDMF

Close USDMF

CEP/COS

Close CEP/COS

Japanese DMF

Found JDMF

305MF10002
Rebamipide (M) at 122, Xuqing Road,...
2023-01-11
Written Confirmation

Close WC

Application Number
305MF10002
Status
 
Filing Details
Rebamipide (M) at 122, Xuqing Road,...
Issue/Submission Date
2023-01-11
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
See all info for this product

See Less

USDMF

Close USDMF

CEP/COS

Close CEP/COS

Japanese DMF

Found JDMF

223MF10143
Rebamipide at 122, Xuqing Road, Xug...
2011-09-28
Written Confirmation

Close WC

Application Number
223MF10143
Status
 
Filing Details
Rebamipide at 122, Xuqing Road, Xug...
Issue/Submission Date
2011-09-28
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
See all info for this product

See Less

USDMF

Found USDMF

38213
Active
SEMAGLUTIDE
2023-03-27
CEP/COS

Close CEP/COS

Japanese DMF

Close JDMF

Written Confirmation

Close WC

Application Number
38213
Status
Active
Fees Unpaid
N/A
 
Filing Details
SEMAGLUTIDE
Issue/Submission Date
2023-03-27
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Post Enquiry
POST ENQUIRY